Teens speak out: how to make birth control counseling more inclusive for transgender youth
NCT ID NCT05726903
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study looked at how to improve contraceptive counseling for transgender and gender diverse adolescents who use or want to use the Depo shot (DMPA). Researchers held focus groups with 35 teens assigned female at birth, aged 15-21, to understand their needs and satisfaction. The goal is to help doctors move beyond assumptions and offer more equitable, gender-affirming care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Depo-subQ Provera (depot medroxyprogesterone acetate, DMPA)
- What this could lead to
- If successful, this study could help doctors provide better, more respectful contraceptive counseling for transgender and gender diverse youth.
- What could go wrong
- This is a small, completed qualitative study with only 35 participants, so findings may not apply to all gender diverse youth. It focuses on satisfaction and counseling, not on medical outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENDER DYSPHORIA, ADOLESCENT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Comprehensive Women's Health Center
Denver, Colorado, 80230, United States